Table of Content

1. Introduction


2. Research Methodology


3. Executive Summary


4. Market Dynamic

4.1 Growth Drivers
4.2 Challenges
4.3 Opportunities


5. United States Molecular Diagnostics Market


6. United States Molecular Diagnostics Market Share Analysis

6.1 By Technology
6.2 By Application
6.3 By Product
6.4 By End User


7. Technology – United States Molecular Diagnostics Market

7.1 Chips and Microarrays
7.2 In Situ Hybridization
7.3 Sequencing
7.4 Mass Spectrometry (MS)
7.5 PCR
7.6 Other Technologies


8. Application – United States Molecular Diagnostics Market

8.1 Pharmacogenomics
8.2 Infectious Disease
8.3 Genetic Disease Screening
8.4 Oncology
8.5 Blood Screening
8.6 Microbiology
8.7 Human Leukocyte Antigen Typing


9. Product – United States Molecular Diagnostics Market

9.1 Instruments
9.2 Reagents
9.3 Other Products


10. End User – United States Molecular Diagnostics Market

10.1 Hospitals
10.2 Laboratories
10.3 Other End Users


11. Porter’s Five Forces Analysis

11.1 Bargaining Power of Buyers
11.2 Bargaining Power of Suppliers
11.3 Degree of Competition
11.4 Threat of New Entrants
11.5 Threat of Substitutes


12. SWOT Analysis

12.1 Strength
12.2 Weakness
12.3 Opportunity
12.4 Threats


13. Key Players Analysis

13.1 F Hoffmann-la Roche Ltd

13.1.1 Overviews
13.1.2 Recent Developments & Strategies
13.1.3 Product Portfolio & Product Launch in Last 1 Year
13.1.4 Revenue

13.2 Illumina Ltd

13.2.1 Overviews
13.2.2 Recent Developments & Strategies
13.2.3 Product Portfolio & Product Launch in Last 1 Year
13.2.4 Revenue

13.3 Hologic Corporation

13.3.1 Overviews
13.3.2 Recent Developments & Strategies
13.3.3 Product Portfolio & Product Launch in Last 1 Year
13.3.4 Revenue

13.4 Agilent Technologies Inc.

13.4.1 Overviews
13.4.2 Recent Developments & Strategies
13.4.3 Product Portfolio & Product Launch in Last 1 Year
13.4.4 Revenue

13.5 Qiagen NV

13.5.1 Overviews
13.5.2 Recent Developments & Strategies
13.5.3 Product Portfolio & Product Launch in Last 1 Year
13.5.4 Revenue

13.6 Myriad Genetics

13.6.1 Overviews
13.6.2 Recent Developments & Strategies
13.6.3 Product Portfolio & Product Launch in Last 1 Year
13.6.4 Revenue

13.7 Abbott Laboratories

13.7.1 Overviews
13.7.2 Recent Developments & Strategies
13.7.3 Product Portfolio & Product Launch in Last 1 Year
13.7.4 Revenue

13.8 Danaher Corporation

13.8.1 Overviews
13.8.2 Recent Developments & Strategies
13.8.3 Product Portfolio & Product Launch in Last 1 Year
13.8.4 Revenue

13.9 Becton, Dickinson and Company

13.9.1 Overviews
13.9.2 Recent Developments & Strategies
13.9.3 Product Portfolio & Product Launch in Last 1 Year
13.9.4 Revenue